FK199B (Zolpidem MR [modified release] Tablet) Phase III Clinical Study -A Double-Blind, Placebo- and Nitrazepam-Controlled, Group-Comparison Study in Patients With Insomnia Associated With Schizophrenia and Manic-Depressive Psychosis.

Trial Profile

FK199B (Zolpidem MR [modified release] Tablet) Phase III Clinical Study -A Double-Blind, Placebo- and Nitrazepam-Controlled, Group-Comparison Study in Patients With Insomnia Associated With Schizophrenia and Manic-Depressive Psychosis.

Completed
Phase of Trial: Phase III

Latest Information Update: 28 Oct 2009

At a glance

  • Drugs Zolpidem (Primary) ; Nitrazepam
  • Indications Insomnia
  • Focus Therapeutic Use
  • Most Recent Events

    • 27 Oct 2009 Actual patient number (450) added as reported by ClinicalTrials.gov.
    • 17 Jul 2008 Actual end date added (June 2008) as reported by ClinicalTrials.gov.
    • 17 Jul 2008 Status changed from in progress to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top